Previous slide
Next slide
SCIENCE AND TECHNOLOGY
AI-empowered platform
for drug discovery
and translational medicine
PARTNERING - COLLABORATION MAKES US BETTER!
AgnistaBio enables its partners to swiftly
(1) discover highly developable native antibody against challenging target protein and its epitopes (cryptic- or multiprotein complex- specific);
(2) identify interacting proteins/enzymes against the target protein and its detail 4D structures for accelerating drug design on a proteome scale in short lead time.
Drug Development
AgnistaAI accelerates the discovery of novel therapeutic antibodies
and uncovers its unexpected interacting proteins to avoid potential side effects in clinics.
